rs2273500

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000744.7(CHRNA4):​c.383+378A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.156 in 1,305,208 control chromosomes in the GnomAD database, including 17,164 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.16 ( 2035 hom., cov: 32)
Exomes 𝑓: 0.16 ( 15129 hom. )

Consequence

CHRNA4
NM_000744.7 intron

Scores

7
Splicing: ADA: 0.00006553
2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -6.67
Variant links:
Genes affected
CHRNA4 (HGNC:1958): (cholinergic receptor nicotinic alpha 4 subunit) This gene encodes a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_addAF=-0.955197).
BP6
Variant 20-63355597-T-C is Benign according to our data. Variant chr20-63355597-T-C is described in ClinVar as [Benign]. Clinvar id is 3255299.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr20-63355597-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.295 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CHRNA4NM_000744.7 linkuse as main transcriptc.383+378A>G intron_variant ENST00000370263.9 NP_000735.1 P43681-1B4DK78Q59FV0
CHRNA4NM_001256573.2 linkuse as main transcriptc.-146+360A>G intron_variant NP_001243502.1 P43681Q4VAQ3B4DK78Q59FV0
CHRNA4NR_046317.2 linkuse as main transcriptn.592+378A>G intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CHRNA4ENST00000370263.9 linkuse as main transcriptc.383+378A>G intron_variant 1 NM_000744.7 ENSP00000359285.4 P43681-1

Frequencies

GnomAD3 genomes
AF:
0.160
AC:
24284
AN:
152010
Hom.:
2032
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.153
Gnomad AMI
AF:
0.118
Gnomad AMR
AF:
0.126
Gnomad ASJ
AF:
0.176
Gnomad EAS
AF:
0.135
Gnomad SAS
AF:
0.308
Gnomad FIN
AF:
0.226
Gnomad MID
AF:
0.229
Gnomad NFE
AF:
0.152
Gnomad OTH
AF:
0.164
GnomAD3 exomes
AF:
0.164
AC:
22355
AN:
136100
Hom.:
2096
AF XY:
0.175
AC XY:
12933
AN XY:
74082
show subpopulations
Gnomad AFR exome
AF:
0.158
Gnomad AMR exome
AF:
0.0818
Gnomad ASJ exome
AF:
0.181
Gnomad EAS exome
AF:
0.137
Gnomad SAS exome
AF:
0.287
Gnomad FIN exome
AF:
0.216
Gnomad NFE exome
AF:
0.149
Gnomad OTH exome
AF:
0.151
GnomAD4 exome
AF:
0.156
AC:
179348
AN:
1153080
Hom.:
15129
Cov.:
30
AF XY:
0.160
AC XY:
90597
AN XY:
565876
show subpopulations
Gnomad4 AFR exome
AF:
0.159
Gnomad4 AMR exome
AF:
0.0835
Gnomad4 ASJ exome
AF:
0.186
Gnomad4 EAS exome
AF:
0.130
Gnomad4 SAS exome
AF:
0.285
Gnomad4 FIN exome
AF:
0.216
Gnomad4 NFE exome
AF:
0.145
Gnomad4 OTH exome
AF:
0.163
GnomAD4 genome
AF:
0.160
AC:
24312
AN:
152128
Hom.:
2035
Cov.:
32
AF XY:
0.164
AC XY:
12190
AN XY:
74382
show subpopulations
Gnomad4 AFR
AF:
0.153
Gnomad4 AMR
AF:
0.126
Gnomad4 ASJ
AF:
0.176
Gnomad4 EAS
AF:
0.136
Gnomad4 SAS
AF:
0.308
Gnomad4 FIN
AF:
0.226
Gnomad4 NFE
AF:
0.152
Gnomad4 OTH
AF:
0.162
Alfa
AF:
0.147
Hom.:
555
Bravo
AF:
0.147
TwinsUK
AF:
0.141
AC:
522
ALSPAC
AF:
0.144
AC:
556
ExAC
AF:
0.163
AC:
3506
Asia WGS
AF:
0.214
AC:
746
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJul 15, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 29% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 27. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.96
T
BayesDel_noAF
Benign
-1.0
CADD
Benign
4.2
DANN
Benign
0.49
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.00039
N
GERP RS
-0.045

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000066
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2273500; hg19: chr20-61986949; COSMIC: COSV64718268; COSMIC: COSV64718268; API